Studies on modified ligands such as glycyrrhizin, lactose, Arg–Gly–Asp peptide, aptamer, and transferrin are extensive and show an increasing trend year over year ( Saleh et al., 2019 ; Stecanella et al., 2021 ; Zheng et al., 2023 ).
← all excerpts
Trend of albumin nanoparticles in oncology: a bibliometric analysis of research progress and prospects.
1
—
—